SCHEMBL23197897

SCHEMBL23197897

CCCCCCC(CCCC)C(C)(C)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.52
CA2 P00918 2/20 0.50
GPR84 Q9NQS5 7/20 0.48
FFAR1 O14842 2/20 0.48
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
MAPK1 P28482 1/20 0.45
HSPD1 P10809 1/20 0.45
BLM P54132 1/20 0.45
HSPE1 P61604 1/20 0.45
GRIK1 P39086 1/20 0.44
GRIK2 Q13002 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688517 0.98 GPR84 (0.50) FDPSCA2GPR84FFAR1MAPT
SCHEMBL5702669 0.98 GPR84 (0.50) FDPSCA2GPR84FFAR1MAPT
Ammonia Solution, Strong SCHEMBL28463038 0.96 GPR84 (0.48) FDPSCA2GPR84FFAR1MAPT
SCHEMBL27396178 0.94 GPR84 (0.47) FDPSCA2GPR84FFAR1MAPT
Ammonia Solution, Strong SCHEMBL27256295 0.92 GPR84 (0.46) FDPSCA2GPR84FFAR1MAPT
SCHEMBL2895726 0.91 ACE2 (0.44) FDPSCA2GPR84FFAR1MAPT
SCHEMBL22181478 0.90 GPR84 (0.47) FDPSCA2GPR84FFAR1MAPT
Ammonia Solution, Strong SCHEMBL27753603 0.89 GPR84 (0.43) FDPSCA2GPR84FFAR1MAPT
Ammonia Solution, Strong SCHEMBL27914146 0.89 GPR84 (0.46) FDPSCA2GPR84FFAR1MAPT
Ammonia Solution, Strong SCHEMBL27840513 0.89 GPR84 (0.46) FDPSCA2GPR84FFAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210101878-A1 Cannabinergic Compounds And Uses Thereof NORTHEASTERN UNIVERSITY 2021-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210101878-A1 Cannabinergic Compounds And Uses Thereof CNR2, CNR1, GPR18 FDPS 3100/4885CA2 2087/4885GPR84 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.